Pacira BioSciences Inc
PCRX
Market Cap$1.22B
Close$
$58.75
133.9% upside
Current Fair Value
133.9% upsideUndervalued by 133.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.22 Billion |
|---|---|
| Enterprise Value | $1.59 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.15 |
| Beta | 0.71 |
| Outstanding Shares | 46,189,500 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -12.27 |
|---|---|
| PEG | 34.57 |
| Price to Sales | 1.67 |
| Price to Book Ratio | 1.57 |
| Enterprise Value to Revenue | 2.26 |
| Enterprise Value to EBIT | -24.75 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.4 |
| Debt to Equity | 0.82 |
Revenue Sources
No data
Insider Trades
ESG Score
No data